3/23
09:58 am
moln
Molecular Partners Publishes Invitation to Annual General Meeting 2026 and Proposes Clare Fisher for Election to its Board of Directors [Yahoo! Finance]
Low
Report
Molecular Partners Publishes Invitation to Annual General Meeting 2026 and Proposes Clare Fisher for Election to its Board of Directors [Yahoo! Finance]
3/19
02:00 am
moln
Molecular Partners Presents New Preclinical Data Highlighting Radio-DARPins’ Amenability to Multiple Isotopes
Medium
Report
Molecular Partners Presents New Preclinical Data Highlighting Radio-DARPins’ Amenability to Multiple Isotopes
3/17
05:14 pm
moln
Molecular Partners to Hold Three Poster Presentations at AACR 2026 [Yahoo! Finance]
Medium
Report
Molecular Partners to Hold Three Poster Presentations at AACR 2026 [Yahoo! Finance]
3/17
04:30 pm
moln
Molecular Partners to Hold Three Poster Presentations at AACR 2026
Medium
Report
Molecular Partners to Hold Three Poster Presentations at AACR 2026
3/16
12:08 pm
moln
Molecular Partners (MOLN) had its "buy" rating reaffirmed by TD Cowen.
Low
Report
Molecular Partners (MOLN) had its "buy" rating reaffirmed by TD Cowen.
3/16
08:03 am
moln
Molecular Partners (MOLN) had its "buy" rating reaffirmed by HC Wainwright. They now have a $13.00 price target on the stock.
Low
Report
Molecular Partners (MOLN) had its "buy" rating reaffirmed by HC Wainwright. They now have a $13.00 price target on the stock.
3/12
10:04 pm
moln
Molecular Partners Reports Highlights and Financial Results for Full Year 2025 [Yahoo! Finance]
High
Report
Molecular Partners Reports Highlights and Financial Results for Full Year 2025 [Yahoo! Finance]
3/12
04:00 pm
moln
Molecular Partners Reports Highlights and Financial Results for Full Year 2025
High
Report
Molecular Partners Reports Highlights and Financial Results for Full Year 2025
2/26
01:28 am
moln
Molecular Partners Announces Participation in March Investor Conferences and Upcoming 2025 Financial Results [Yahoo! Finance]
Medium
Report
Molecular Partners Announces Participation in March Investor Conferences and Upcoming 2025 Financial Results [Yahoo! Finance]
2/26
01:13 am
moln
Molecular Partners Signs Development Agreement with Eckert & Ziegler for Targeted Alpha Radiotherapeutics [Yahoo! Finance]
Medium
Report
Molecular Partners Signs Development Agreement with Eckert & Ziegler for Targeted Alpha Radiotherapeutics [Yahoo! Finance]
2/26
01:00 am
moln
Molecular Partners Announces Participation in March Investor Conferences and Upcoming 2025 Financial Results
Medium
Report
Molecular Partners Announces Participation in March Investor Conferences and Upcoming 2025 Financial Results
2/26
01:00 am
moln
Molecular Partners Signs Development Agreement with Eckert & Ziegler for Targeted Alpha Radiotherapeutics
Medium
Report
Molecular Partners Signs Development Agreement with Eckert & Ziegler for Targeted Alpha Radiotherapeutics
2/2
04:15 pm
moln
Molecular Partners AG (MOLN) Discusses Clinical Imaging and Dosimetry Data for DLL3 Targeting Radiotherapeutic MPO712 Transcript [Seeking Alpha]
Low
Report
Molecular Partners AG (MOLN) Discusses Clinical Imaging and Dosimetry Data for DLL3 Targeting Radiotherapeutic MPO712 Transcript [Seeking Alpha]
2/2
03:38 pm
moln
Molecular Partners Highlights Favorable MP0712 DLL3 Radiotherapeutic Imaging, U.S. Phase I/II Ready [Yahoo! Finance]
Medium
Report
Molecular Partners Highlights Favorable MP0712 DLL3 Radiotherapeutic Imaging, U.S. Phase I/II Ready [Yahoo! Finance]
2/2
02:17 am
moln
Molecular Partners Announces Presentation of First Imaging and Dosimetry Data of DLL3-Targeting Radiotherapy MP0712 in Patients at TWC 2026 [Yahoo! Finance]
Medium
Report
Molecular Partners Announces Presentation of First Imaging and Dosimetry Data of DLL3-Targeting Radiotherapy MP0712 in Patients at TWC 2026 [Yahoo! Finance]
2/2
01:00 am
moln
Molecular Partners Announces Presentation of First Imaging and Dosimetry Data of DLL3-Targeting Radiotherapy MP0712 in Patients at TWC 2026
Medium
Report
Molecular Partners Announces Presentation of First Imaging and Dosimetry Data of DLL3-Targeting Radiotherapy MP0712 in Patients at TWC 2026
1/28
07:29 am
moln
Molecular Partners (NASDAQ:MOLN) was upgraded by analysts at HC Wainwright to a "strong-buy" rating.
Low
Report
Molecular Partners (NASDAQ:MOLN) was upgraded by analysts at HC Wainwright to a "strong-buy" rating.
1/27
07:19 am
moln
Molecular Partners (NASDAQ:MOLN) is now covered by analysts at HC Wainwright. They set a "buy" rating on the stock.
Medium
Report
Molecular Partners (NASDAQ:MOLN) is now covered by analysts at HC Wainwright. They set a "buy" rating on the stock.
1/11
03:18 pm
moln
Molecular Partners Highlights Clinical Development Progress and Anticipated Milestones at 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Low
Report
Molecular Partners Highlights Clinical Development Progress and Anticipated Milestones at 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
1/11
03:00 pm
moln
Molecular Partners Highlights Clinical Development Progress and Anticipated Milestones at 44th Annual J.P. Morgan Healthcare Conference
Low
Report
Molecular Partners Highlights Clinical Development Progress and Anticipated Milestones at 44th Annual J.P. Morgan Healthcare Conference